Applying science to care.

Medavera identifies gaps in knowledge and care, methodically researches the subject matter, identifies the top experts to guide the content, and then utilizes a format that will provide the best learning opportunity. We are always looking for new teaching methods and technologies in order to offer stimulating and actionable medical education. Medical education must be meaningful to become applied to clinical practice. Great content, respected leaders, and interesting formats create successful interactions and learning.
FEATURED PROJECTS

Reducing Opioids in Surgical Pain Management:
Exploring New Perioperative and Postoperative Strategies

Wednesday, April 18, 2018
5:00 - 6:00 pm ET

Register online at OpioidReduction.com

The U.S. opioid epidemic continues and strategies are needed to reduce their use before and after surgery, and for long-term pain management. This webinar presented by Drs. R. Corey Waller, Jay Kuchera, Sarah E. Rebstock, and Daniel H. Sajewski is accredited for physicians, nurses, and pharmacists.

Complimentary CME & CE Credits. There is no charge for the program or certificate, but registration is required for the webinar, access to the slides, and online post-test CME assessment.

Planned and developed by Medavera, Inc. and supported by an educational grant from Cumberland Pharmaceuticals, Inc.

Medavera, Inc. has partnered with Envision to provide this program to healthcare professionals.

THE MEDICAL NEWS
(Reuters) - A federal appeals court on Thursday declared unconstitutional an Indiana law signed by then-Governor Mike Pence that banned women from having abortions because of the gender, race or disability, including Down's syndrome, of their fetuses.... (Reuters) - Biogen Inc struck a $1 billion neurology drug development deal with Ionis Pharmaceuticals on Friday, expanding a partnership that developed the company's potential blockbuster drug for spinal muscular atrophy.... FRANKFURT (Reuters) - Merck KGaA will seek development partners for experimental treatments including tepotinib as the German company looks to licensing deals to help fund clinical trials, according to its head of drug R&D.... ZURICH (Reuters) - Swiss drugmaker Novartis' first quarterly results under new CEO Vas Narasimhan have been marred by a prized psoriasis treatment that disappointed and a sharp slump in sales by its U.S. generics unit.... BUDAPEST (Reuters) - A Hungarian laboratory worker has been isolated at a Budapest hospital after accidental exposure to the deadly Ebola virus but has shown no symptoms so far, health officials said on Friday.... BOSTON (Reuters) - Alnylam Pharmaceuticals Inc said on Friday that Dicerna Pharmaceuticals Inc will pay it $25 million in cash and stock to resolve a lawsuit claiming it stole trade secrets about gene-silencing technology used to develop drug treatments.... (Reuters Health) - Many children hospitalized in the U.S. for brain injuries don't receive all the rehabilitation services needed for them to potentially make a full recovery, a new study suggests.... (Reuters Health) - Narcotic painkillers can be particularly dangerous for patients who also take tranquilizing drugs known as benzodiazepines, but a study suggests doctors are still over-prescribing this combination of medicines.... (Reuters Health) - Older adults who lose a spouse may be more vulnerable to cognitive decline in subsequent years and require extra support and monitoring, researchers say.... TOKYO (Reuters) - A Japanese woman born in the final year of the 19th century and believed to have been the world's oldest person died on Saturday, Kyodo news agency said. She was 117....